Home  >  Products  >  NARG1 (NMDA receptor regulated 1) Blocking Peptide (the N terminal of protein) (100ug)
NARG1 (NMDA receptor regulated 1) Blocking Peptide (the N terminal of protein) (100ug)

NARG1 (NMDA receptor regulated 1) Blocking Peptide (the N terminal of protein) (100ug)

Supplier: Aviva Systems Biology Incorporated
Star_fadedStar_fadedStar_fadedStar_fadedStar_faded
0 reviews | Write a Review Pencil
This is a synthetic peptide designed for use in combination with anti-NARG1 antibody (Catalogue #: ARP48989_P050) made by Aviva Systems Biology. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.
Presku: AAP48989
Size: 100 ug
Weight: 101kDa
Gene: 80155
Format: Lyophilized powder
Target: The ARD1A-NARG1 complex displays alpha (N-terminal) acetyltransferase activity that may be important for vascular, hematopoietic and neuronal growth and development. NARG1 is required to control retinal neovascularization in adult ocular endothelial cells. In complex with G22P1 and XRCC5 (Ku80), up-regulates transcription from the osteocalcin promoter.This gene encodes a protein of unknown function. However, similarity to proteins in yeast and other species suggests that this protein may be an N-acetyltransferase. Publication Note: This RefSeq record includes a subset of the publications that are available for this gene. Please see the Entrez Gene record to access additional publications.
Alternative names: Ga19; NATH; TBDN100
See Full Product Listings >